Skip Navigation

European Heart Journal 2001 22(24):2243-2252; doi:10.1053/euhj.2001.2678
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (173)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Humphries, S.E.
Right arrow Articles by Miller, G.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Humphries, S.E.
Right arrow Articles by Miller, G.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The interleukin-6 –174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men

S.E. Humphriesa,f1, L.A. Luonga, M.S. Ogga, E. Hawea and G.J. Millerb

a Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Department of Medicine, Royal Free and University College London Medical School, London, U.K.
b MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, Medical College of St. Bartholomew's Hospital, London, U.K.

revised February 20, 2001; accepted February 21, 2001

Abstract

Aims Inflammation is a key component of coronary heart disease, and genes coding for cytokines are candidates for predisposing to coronary heart disease risk. We have examined the effect of two polymorphisms (–174G>C and –572G>C) in the promoter of the interleukin-6 (IL-6) gene on risk of coronary heart disease, and on intermediate risk traits including fibrinogen and systolic blood pressure, in 2751 middle-aged healthy U.K. men.

Results The –174C allele (frequency 0·43, 95% CI 0·42–0·44) was not associated with significant effects on fibrinogen levels, but was associated with a significantly (P=0·007) higher systolic blood pressure (mean mmHg (95% CI): GG=135·5 (134·3–136·7); GC=137·9 (136·9–138·9); CC= 138·0 (136·3–139·8)). This effect was of similar magnitude in smokers and non-smokers, and was greater in men in the top two tertiles of body mass index (>24·86kg.m–2) than in those in the bottom tertile. Compared to those with the genotype GG, men carrying the –174C allele had a relative risk of coronary heart disease of 1·54 (95% CI 1·0–2·23, P=0·048) and this effect was greatest in smokers (compared to GG non-smokers, RR 2·66, CI 1·64–4·32). These effects remained statistically significant after adjusting for classical risk factors including blood pressure (P=0·04). The –572C allele (frequency 0·05, 0·04–0·06) was not associated with a significant effect on blood pressure, fibrinogen or relative risk of coronary heart disease. In a subset of the genotyped men (n=494), carriers of the –174C allele had higher levels of C-reactive protein than non-carriers.

Conclusions These data confirm the importance of the inflammatory system in the development of coronary heart disease. They suggest that, at least in part, the effect of the IL-6 –174G>C polymorphism on blood pressure is likely to be operating through inflammatory mechanisms, but the genotype effect on coronary heart disease risk is largely unexplained by its effect on blood pressure. The molecular mechanisms whereby genetically determined differences in plasma levels of IL-6 are having these effects remain to be determined.

Key Words: Interleukin-6, polymorphisms, systolic blood pressure, inflammation, prospective study, smoking

f1 Correspondence: Professor Steve Humphries, Division of Cardiovascular Genetics, Department of Medicine, UCL Medical School, Rayne Institute, University Street, London WC1E 6JJ, U.K.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Aker, C. Bantis, P. Reis, N. Kuhr, C. Schwandt, B. Grabensee, P. Heering, and K. Ivens
Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2847 - 2851.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Vlachopoulos, D. Terentes-Printzios, I. Dima, K. Aznaouridis, and C. Stefanadis
Polymorphisms of Inflammatory Markers/Mediators and Arterial Stiffness
Hypertension, June 1, 2009; 53(6): e39 - e39.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, K. M. J. Douglas, J. P. Smith, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, and G. D. Kitas
Transforming growth factor-{beta}1 869T/C, but not interleukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis
Rheumatology, February 1, 2009; 48(2): 113 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Corella, J. I. Gonzalez, M. Bullo, P. Carrasco, O. Portoles, J. Diez-Espino, M. I. Covas, V. Ruiz-Gutierrez, E. Gomez-Gracia, F. Aros, et al.
Polymorphisms Cyclooxygenase-2 -765G>C and Interleukin-6 -174G>C Are Associated with Serum Inflammation Markers in a High Cardiovascular Risk Population and Do Not Modify the Response to a Mediterranean Diet Supplemented with Virgin Olive Oil or Nuts
J. Nutr., January 1, 2009; 139(1): 128 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Shen, D. K. Arnett, P. Perez-Martinez, L. D. Parnell, C.-Q. Lai, J. M. Peacock, J. E. Hixson, M. Y. Tsai, R. J. Straka, P. N. Hopkins, et al.
The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN study,boxs
J. Lipid Res., August 1, 2008; 49(8): 1839 - 1845.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Trichopoulou, N. Yiannakouris, C. Bamia, V. Benetou, D. Trichopoulos, and J. M. Ordovas
Genetic Predisposition, Nongenetic Risk Factors, and Coronary Infarct
Arch Intern Med, April 28, 2008; 168(8): 891 - 896.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W.-C. Liao, J.-T. Lin, C.-Y. Wu, S.-P. Huang, M.-T. Lin, A. S.-H. Wu, Y.-J. Huang, and M.-S. Wu
Serum Interleukin-6 Level but not Genotype Predicts Survival after Resection in Stages II and III Gastric Carcinoma
Clin. Cancer Res., January 15, 2008; 14(2): 428 - 434.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M H A Malik, F Jury, A Bayat, W E R Ollier, and P R Kay
Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor
Ann Rheum Dis, August 1, 2007; 66(8): 1116 - 1120.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. E. Humphries, J. A. Cooper, P. J. Talmud, and G. J. Miller
Candidate Gene Genotypes, Along with Conventional Risk Factor Assessment, Improve Estimation of Coronary Heart Disease Risk in Healthy UK Men
Clin. Chem., January 1, 2007; 53(1): 8 - 16.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Shaw
Genetics of postoperative complications following thoracic surgery.
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L Morgan, J Cooper, H Montgomery, N Kitchen, and S E Humphries
The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms
J. Neurol. Neurosurg. Psychiatry, August 1, 2006; 77(8): 915 - 917.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Yamada, N. Metoki, H. Yoshida, K. Satoh, S. Ichihara, K. Kato, T. Kameyama, K. Yokoi, H. Matsuo, T. Segawa, et al.
Genetic Risk for Ischemic and Hemorrhagic Stroke
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1920 - 1925.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
E. J. C. de Geus
Genetic pleiotropy in depression and coronary artery disease.
Psychosom Med, March 1, 2006; 68(2): 185 - 186.
[Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. M. McCaffery, N. Frasure-Smith, M.-P. Dube, P. Theroux, G. A. Rouleau, Q. Duan, and F. Lesperance
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.
Psychosom Med, March 1, 2006; 68(2): 187 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Liu, Y. Berthier-Schaad, M. D. Fallin, N. E. Fink, R. P. Tracy, M. J. Klag, M. W. Smith, and J. Coresh
IL-6 Haplotypes, Inflammation, and Risk for Cardiovascular Disease in a Multiethnic Dialysis Cohort
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 863 - 870.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. P.S. Sie, F. A. Sayed-Tabatabaei, H.-H. S. Oei, A. G. Uitterlinden, H. A.P. Pols, A. Hofman, C. M. van Duijn, and J. C.M. Witteman
Interleukin 6 -174 G/C Promoter Polymorphism and Risk of Coronary Heart Disease: Results from the Rotterdam Study and a Meta-Analysis
Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 212 - 217.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Bruunsgaard
Physical activity and modulation of systemic low-level inflammation
J. Leukoc. Biol., October 1, 2005; 78(4): 819 - 835.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Leibovici, H. B. Grossman, C. P. Dinney, R. E. Millikan, S. Lerner, Y. Wang, J. Gu, Q. Dong, and X. Wu
Polymorphisms in Inflammation Genes and Bladder Cancer: From Initiation to Recurrence, Progression, and Survival
J. Clin. Oncol., August 20, 2005; 23(24): 5746 - 5756.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. D. Shaw, A. A. Vaporciyan, X. Wu, T. M. King, M. R. Spitz, J. B. Putnam, and B. F. Dickey
Inflammatory Gene Polymorphisms Influence Risk of Postoperative Morbidity After Lung Resection
Ann. Thorac. Surg., May 1, 2005; 79(5): 1704 - 1710.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Weger, I. Steinbrugger, A. Haas, W. Marz, Y. El-Shabrawi, W. Weger, O. Schmut, and W. Renner
Role of the Interleukin-6 -174 G>C Gene Polymorphism in Retinal Artery Occlusion
Stroke, February 1, 2005; 36(2): 249 - 252.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
A. Huber, C. Grimm, S. Jirecek, R. Zeillinger, K. Heim, P. Husslein, and L. Hefler
An lnterleukin-6 Gene Promoter Polymorphism and Unexplained Late Intrauterine Fetal Death: A Multicenter Study
Reproductive Sciences, January 1, 2005; 12(1): 33 - 36.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
M. Bennermo, C. Held, S. Stemme, C.-G. Ericsson, A. Silveira, F. Green, and P. Tornvall
Genetic Predisposition of the Interleukin-6 Response to Inflammation: Implications for a Variety of Major Diseases?
Clin. Chem., November 1, 2004; 50(11): 2136 - 2140.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. J. Freeman, F. McManus, E. A. Brown, L. Cherry, J. Norrie, J. E. Ramsay, P. Clark, I. D. Walker, N. Sattar, and I. A. Greer
Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia
Hypertension, November 1, 2004; 44(5): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. J. Kunicki, A. B. Federici, D. R. Salomon, J. A. Koziol, S. R. Head, T. S. Mondala, J. D. Chismar, L. Baronciani, M. T. Canciani, and I. R. Peake
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees
Blood, October 15, 2004; 104(8): 2359 - 2367.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. R. Harding, S. Dhamrait, A. Whitelaw, S. E. Humphries, N. Marlow, and H. E. Montgomery
Does Interleukin-6 Genotype Influence Cerebral Injury or Developmental Progress After Preterm Birth?
Pediatrics, October 1, 2004; 114(4): 941 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J J McCarthy, A Parker, R Salem, D J Moliterno, Q Wang, E F Plow, S Rao, G Shen, W J Rogers, L K Newby, et al.
Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes
J. Med. Genet., May 1, 2004; 41(5): 334 - 341.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. E. Humphries, P. M. Ridker, and P. J. Talmud
Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation?
Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 628 - 636.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. DeMichele, A.-M. Martin, R. Mick, P. Gor, L. Wray, M. Klein-Cabral, G. Athanasiadis, T. Colligan, E. Stadtmauer, and B. Weber
Interleukin-6 -174G->C Polymorphism Is Associated with Improved Outcome in High-Risk Breast Cancer
Cancer Res., November 15, 2003; 63(22): 8051 - 8056.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. Harding, S. Dhamrait, A. Millar, S. Humphries, N. Marlow, A. Whitelaw, and H. Montgomery
Is Interleukin-6 -174 Genotype Associated With the Development of Septicemia in Preterm Infants?
Pediatrics, October 1, 2003; 112(4): 800 - 803.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. M.L. Chapman, J. P. Beilby, S. E. Humphries, L. J. Palmer, P. L. Thompson, and J. Hung
Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population
Eur. Heart J., August 2, 2003; 24(16): 1494 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Landi, V. Moreno, L. Gioia-Patricola, E. Guino, M. Navarro, J. de Oca, G. Capella, and F. Canzian
Association of Common Polymorphisms in Inflammatory Genes Interleukin (IL)6, IL8, Tumor Necrosis Factor {alpha}, NFKB1, and Peroxisome Proliferator-activated Receptor {gamma} with Colorectal Cancer ,
Cancer Res., July 1, 2003; 63(13): 3560 - 3566.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. A. Hefler, C. Grimm, S. Ackermann, S. Malur, A. R. Radjabi-Rahat, S. Leodolter, M. W. Beckmann, R. Zeillinger, H. Koelbl, and C. B. Tempfer
An Interleukin-6 Gene Promoter Polymorphism Influences the Biological Phenotype of Ovarian Cancer
Cancer Res., June 15, 2003; 63(12): 3066 - 3068.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. G. L. Biondi-Zoccai, A. Abbate, G. Liuzzo, and L. M. Biasucci
Atherothrombosis, inflammation, and diabetes
J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1071 - 1077.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Pola, A. Flex, E. Gaetani, R. Flore, M. Serricchio, and P. Pola
Synergistic Effect of -174 G/C Polymorphism of the Interleukin-6 Gene Promoter and 469 E/K Polymorphism of the Intercellular Adhesion Molecule-1 Gene in Italian Patients With History of Ischemic Stroke
Stroke, April 1, 2003; 34(4): 881 - 885.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Jerrard-Dunne, M. Sitzer, P. Risley, D. A. Steckel, A. Buehler, S. von Kegler, and H. S. Markus
Interleukin-6 Promoter Polymorphism Modulates the Effects of Heavy Alcohol Consumption on Early Carotid Artery Atherosclerosis: The Carotid Atherosclerosis Progression Study (CAPS)
Stroke, February 1, 2003; 34(2): 402 - 407.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A.H. Gomma, M.A. Elrayess, C.J. Knight, E. Hawe, K.M. Fox, and S.E. Humphries
The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis
Eur. Heart J., December 2, 2002; 23(24): 1955 - 1962.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. S. Jenny, R. P. Tracy, M. S. Ogg, L. A. Luong, L. H. Kuller, A. M. Arnold, A. R. Sharrett, and S. E. Humphries
In the Elderly, Interleukin-6 Plasma Levels and the -174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease
Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 2066 - 2071.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. S. Athan, J. H. Lee, A. Arriaga, R. P. Mayeux, and B. Tycko
Polymorphisms in the Promoter of the Human APP Gene: Functional Evaluation and Allele Frequencies in Alzheimer Disease
Arch Neurol, November 1, 2002; 59(11): 1793 - 1799.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Papafili, M. R. Hill, D. J. Brull, R. J. McAnulty, R. P. Marshall, S. E. Humphries, and G. J. Laurent
Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1631 - 1636.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. A. Mitchison and J. Roes
Patterned variation in murine MHC promoters
PNAS, August 6, 2002; 99(16): 10561 - 10566.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Basso, G. D.O. Lowe, A. Rumley, A. D. McMahon, and S. E. Humphries
Interleukin-6 -174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS)
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 599 - 604.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
N. Lamblin, C. Bauters, and N. Helbecque
Gene polymorphisms of pro- (or anti-) inflammatory cytokines and vascular disease
Eur. Heart J., December 2, 2001; 22(24): 2219 - 2220.
[PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Basso, G. D.O. Lowe, A. Rumley, A. D. McMahon, and S. E. Humphries
Interleukin-6 -174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS)
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 599 - 604.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.